CML Treated With Bosutinib After Relapse

Summary

Prospective, open label, multicenter, phase II study evaluating correlation of SNPs with efficacy and toxicity in patients treated with Bosutinib. A total of 50 patients with previously treated Ph+ chronic phase CML will be included in the study

Timeline

Start

2015-05

Primary completion

2018-12

Completion

2019-06-27

Drugs

Indications